The clinical information you need, at your fingertips.

Clinicians are rapidly adopting AI tools, but persistent concerns about accuracy and accountability continue to limit trust. . .

Updated guidance highlights biennial mammography for most average-risk women, with shared decision making at the margins. . .

Focal segmental glomerulosclerosis is a heterogeneous podocytopathy that causes progressive proteinuric kidney disease and represents a leading cause of nephrotic syndrome and end-stage kidney disease. . .

Phase 2 trial finds elraglusib plus standard chemotherapy improves survival in a hard to treat population. . .

In a head-to-head trial, magnetic seizure therapy worked about as well as electroconvulsive therapy for severe depression and caused fewer memory problems. . .

A nine-protein blood test identified long-term kidney risk in Black adults carrying high-risk APOL1 variants who had normal kidney function, with the highest-risk group facing far more events over 10 years. . .

In statin-treated, high-risk patients, oral enlicitide lowered LDL‑C ~65% at 8 weeks—far exceeding ezetimibe and bempedoic acid—with similar short-term safety. . .

Short-term nitrogen dioxide exposure was associated with a markedly higher likelihood of migraine-related urgent care, while longer-term pollution exposure tracked with greater triptan use. . .